Bowen Acquisition Corp

Bowen Acquisition Corp

BOWN
Bowen Acquisition CorpUS flagNASDAQ Global Market
9.19
USD
-0.01
- -
27.52MMarket Cap
Bowen Acquisition Corp
BOWN
(NASDAQ Global Market)

Recent

price

9.19

P/E

ratio

- -

div

yld

- -

ROIC.AI

2023
2024
TTM
FRC
- -
- -
- -
Revenue per Share
0.71
1.31
0.03
Basic EPS, GAAP
-0.14
-0.14
-0.1
Free Cash Flow per Basic Share
- -
- -
- -
Dividend per Share
34.27
33.09
2.49
Book Value per Share
34.27
33.09
2.55
Tangible Book Value per Share
2
2
3
Basic Weighted Avg Shares
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Operating Margin (%)
- -
- -
- -
Depreciation Expense
1
3
- -
Net Income, GAAP
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
Profit Margin (%)
- -
-1
-2
Working Capital
- -
- -
- -
LT Debt
72
75
6
Total Equity
- -
- -
- -
Return on Invested Capital (%)
- -
4.14
12.68
Return on Capital (%)
- -
4.04
4.59
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
1
1
1
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
9
3
3
Market Capitalization
50
36
26

Working Capital

FRC

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
3
2
Payables & Accruals
- -
1
1
ST Debt
1
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
4.42%
Free Cash Flow
- -
- -
10.63%
Net Income, GAAP
- -
- -
99.61%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.71
2024
0.35
0.09
0.37
- -
1.31
2025
-0.9
0.25
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Business
Bowen Acquisition Corp is a Cayman Islands exempted blank check company formed for the purpose of effecting mergers, share exchanges, asset acquisitions, stock purchases, recapitalizations, reorganizations, or similar business combinations with one or more businesses or entities. The company primarily focuses on identifying prospective target businesses with an initial geographic emphasis on Asia, although it does not restrict itself to any specific industry or region. Bowen Acquisition Corp does not produce or sell products directly but engages in acquiring and merging with target companies to facilitate market entry and growth. Its latest major development includes entering into a merger agreement with Shenzhen Qianzhi BioTechnology Co., Ltd., a China-based health and wellness biotech firm specializing in the development, manufacturing, and sales of ozonated health and wellness products such as antibacterial, skincare, gynecological, and andrological applications. This business combination aims to expand Bowen’s portfolio by integrating Qianzhi BioTech’s proprietary ozonated disinfectants and plant-based formulations, which are considered safer and more environmentally friendly alternatives to traditional disinfectants. Bowen Acquisition Corp completed a $60 million initial public offering in mid-2023 to support its strategic initiatives and recently amended and extended the merger agreement with Qianzhi BioTech into late 2025. Headquartered in New York, the company operates within the dynamic special purpose acquisition company (SPAC) sector, leveraging strategic partnerships and acquisitions to create shareholder value through business combinations primarily focused on the Asian market.

Company News

APIChat
  • Bowen Acquisition Corp Receives NASDAQ Delisting Notification for Failure to Comply with Listing Requirements

  • Bowen Acquisition Corp Receives NASDAQ Notification of Non-Compliance with Listing Rules